News
Handwriting is a complex process requiring brain-hand coordination and research shows it is substantially affected by ...
1h
Kyodo News on MSNFinal phase of trial for Parkinson's drug to treat Alzheimer's begins in JapanThe final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...
2h
Vietnam Investment Review on MSNXellSmart gains FDA clearance for three iPSC cell therapiesXellSmart has completed multiple cases of iPSC-derived dopaminergic neural progenitor cell therapy for patients with ...
Giving prosthetics real feeling and controllable with mind, or treating epilepsy, Alzheimer's, depression, Parkinson’s and other neurological disorders, ... Chinese researchers have successfully ...
THIRUVANANTHAPURAM: The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has transferred five ...
Parkinson Canada hosted Parkinson’s IQ + You, a free, in-person event designed to support people living with Parkinson’s ...
19h
IEEE Spectrum on MSNA Pen With Magnetic Ink Could Test for Parkinson’s DiseaseParkinson’s disease can be difficult to diagnose, but one common symptom of the progressive neurodegenerative condition is ...
Most people who drink coffee appreciate the quick jolt of energy it provides. But in a new study, presented today at the ...
A new way of thinking about Alzheimer's disease has yielded a discovery that could be the key to stopping the cognitive ...
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them
Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results